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ABSTRACT
This study was designed to investigate whether calcium-acti-
vated potassium channels of small (SKCa or KCa2) and interme-
diate (IKCa or KCa3.1) conductance activated by 6,7-dichloro-
1H-indole-2,3-dione 3-oxime (NS309) are involved in both nitric
oxide (NO) and endothelium-derived hyperpolarizing factor
(EDHF)-type relaxation in large and small rat mesenteric arter-
ies. Segments of rat superior and small mesenteric arteries
were mounted in myographs for functional studies. NO was
recorded using NO microsensors. SKCa and IKCa channel cur-
rents and mRNA expression were investigated in human um-
bilical vein endothelial cells (HUVECs), and calcium concentra-
tions were investigated in both HUVECs and mesenteric arterial
endothelial cells. In both superior (1093 m) and small mes-
enteric (300 m) arteries, NS309 evoked endothelium- and
concentration-dependent relaxations. In superior mesenteric
arteries, NS309 relaxations and NO release were inhibited by
both NG,NG-asymmetric dimethyl-L-arginine (ADMA) (300 M),
an inhibitor of NO synthase, and apamin (0.5 M) plus 1-[(2-
chlorophenyl)diphenylmethyl]-1H-pyrazole (TRAM-34) (1 M),
blockers of SKCa and IKCa channels, respectively. In small
mesenteric arteries, NS309 relaxations were reduced slightly by
ADMA, whereas apamin plus an IKCa channel blocker almost
abolished relaxation. Iberiotoxin did not change NS309 relax-
ation. HUVECs expressed mRNA for SKCa and IKCa channels,
and NS309 induced increases in calcium, outward current, and
NO release that were blocked by apamin and TRAM-34 or
charybdotoxin. These findings suggest that opening of SKCa
and IKCa channels leads to endothelium-dependent relaxation
that is mediated mainly by NO in large mesenteric arteries and
by EDHF-type relaxation in small mesenteric arteries. NS309-
induced calcium influx appears to contribute to the formation
of NO.
Introduction
The vascular endothelium plays a major role in the regula-
tion of blood flow. Through the release of vasoactive agents, the
endothelium may decrease the contraction level of vascular
smooth muscle and hence increase blood flow. The vasoactive
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agents released by the endothelium include nitric oxide (NO),
prostacyclin, and factors involved in endothelium-dependent
hyperpolarizing factor (EDHF)-type relaxation (Fe´le´tou and
Vanhoutte, 1988, 2009). The production of endothelium-
dependent relaxing factors generally involves an increase in the
intracellular Ca2 concentration [Ca2]i. An increase in endo-
thelial [Ca2]i will open calcium-activated potassium channels
of small (SKCa or KCa2) and intermediate (IKCa or KCa3.1)
conductance, thereby hyperpolarizing the endothelial cell.
These channels have been acknowledged as a required compo-
nent for the activation of EDHF-type relaxation (Burnham et
al., 2002; Bychkov et al., 2002; Eichler et al., 2003). In vivo
studies in mice show that suppression of the SKCa3 channel
(Taylor et al., 2003), knockout of the IKCa channel (Si et al.,
2006), and deficit of both SKCa3 and IKCa channels (Bra¨hler et
al., 2009) lead to elevated blood pressure. In addition, opening
SKCa and IKCa channels decreases myogenic tone, increases
acetylcholine (ACh)-induced relaxation in rat cremaster arteri-
oles (Sheng et al., 2009), and restores attenuated EDHF-type
relaxation in mesenteric small arteries from Zucker diabetic
fatty rats (Brøndum et al., 2010). Moreover, opening IKCa chan-
nels decreases mean arterial blood pressure in angiotensin II-
induced hypertensive mice (Sankaranarayanan et al., 2009)
and conscious dogs (Damkjaer et al., 2011). These results sup-
port findings that SKCa and IKCa channels are involved in
controlling blood pressure and organ blood flow, and this often
is attributed to EDHF-type relaxation. However, recent studies
suggest that SKCa and IKCa channel opening also is associated
with the activation of NO synthase and NO production
(Stankevicius et al., 2006; Sheng and Braun, 2007; Bra¨hler et
al., 2009; Sheng et al., 2009; Dalsgaard et al., 2010a). In addi-
tion, mechanisms involved in SKCa and IKCa channel activation
leading to vasodilation are largely unknown.
Therefore, the present study investigated the effects of open-
ing endothelial SKCa and IKCa channels by the use of 6,7-
dichloro-1H-indole-2,3-dione 3-oxime (NS309) in a large artery
and small artery and hypothesized that opening of endothelial
SKCa and IKCa channels would lead to NO-induced relaxation
in large arteries and EDHF-type relaxation in small arteries.
NS309 is an activator of SKCa and IKCa channels in human
epithelial kidney cells, possibly acting through increasing the
channel sensitivity for Ca2 (Strøbaek et al., 2004). Therefore,
we chose to characterize the effects of the compound in human
umbilical vein endothelial cells (HUVECs) by patch-clamp stud-
ies and to address how the compound may lead to NO release by
measuring NS309-induced changes in [Ca2]i in HUVECs and
freshly isolated mesenteric arterial endothelial cells.
Materials and Methods
Rat Mesenteric Arteries. Adult male Wistar rats (12 weeks old)
were killed in accordance with a protocol from the Guide for the Care
and Use of Laboratory Animals (Institute of Laboratory Animal
Resources, 1996). The protocol was approved by The Danish Ministry
of Justice (permission 2005/561-964). The mesenteric vascular bed
was isolated, and the superior mesenteric artery and third-order
small mesenteric arteries were dissected, isolated, and transferred
into cold physiological saline solution (PSS) of the following compo-
sition: 119 mM NaCl, 4.7 mM KCl, 5.5 mM glucose, 1.17 mM MgSO4,
25 mM NaHCO, 1.18 mM KH2PO4, 1.6 mM CaCl2, and 0.026 mM
EDTA. The solution was equilibrated with bioair of the composition
5% CO2, 21% O2, and 74% N2 to maintain pH at 7.4.
Isometric Tension Recordings. Superior mesenteric arteries
(internal diameter, 1093  9 m; n  39) were mounted on two
100-m wires in a wire myograph (model 310A; DMT, Aarhus, Den-
mark) for isometric tension recordings and normalized as described
previously (Simonsen et al., 1999). In brief, arterial segments were
stretched to their optimal lumen diameters for active tension devel-
opment (i.e., to an internal circumference of 90% of that achieved
when the vessels were exposed to a passive tension yielding a trans-
mural pressure of 100 mm Hg) (Simonsen et al., 1999). Segments
were discarded if noradrenalin-induced (5 M) contraction was 10
kPa or if ACh-induced (10 M) relaxation on noradrenalin-induced (5
M) contraction was 75%.
To investigate the role of opening SKCa and IKCa channels in
tension, arterial segments were incubated with NG,NG-asymmetric
dimethyl-L-arginine (ADMA) (300 M), the SKCa channel blocker
apamin (0.5 M), and the IKCa channel blocker 1-[(2-chlorophenyl)
diphenylmethyl]-1H-pyrazole (TRAM-34) (1 M). Unless otherwise
stated, arterial segments always were incubated with the cyclooxy-
genase inhibitor indomethacin (3 M). After 30 min of incubation
with the inhibitor and/or blocker, segments were contracted with
norepinephrine (0.5 M) to constrict the vessel to 60 to 70% of the
maximal response. When contraction was stable, cumulative concen-
tration-response curves for NS309 (0.01–10 M) were constructed,
and changes in tension were recorded.
Isobaric Tension Recordings. Third-order mesenteric small ar-
teries (internal diameter, 300  30 m; n  34) were mounted in a
myograph (model 110P; DMT), where pressure and flow could be ad-
justed as described previously (Thorsgaard et al., 2003). In brief, the
arterial segment was mounted on two micropipettes and viewed
through an inverted microscope equipped with a charge-coupled device
video camera linked to a personal computer via a frame grabber. Hy-
drostatic pressures of both inlet and outlet reservoirs were measured by
pressure transducers connected to the perfusion line on the inlet and
outlet sides, respectively, and the segment was pressurized to 50 mm
Hg. The inclusion criteria for the arterial segments were as follows:
1) the contractile response induced by 11-dideoxy-9a,11a-epoxymetha-
noprostaglandin F2 (U46619) (10 nM) should reduce vessel diameter
by at least 25%, 2) relaxation evoked by ACh (10 M) should be 	50%
of U46619-induced constriction, and 3) if an air bubble passed
through the arterial segment, then the experiment was excluded.
Unless otherwise stated, arterial segments always were incubated
with indomethacin (3 M).
To investigate the role of opening SKCa and IKCa channels in
vessel diameter, arterial segments were incubated with ADMA (300
M), apamin (0.5 M), the IKCa channel blockers TRAM-34 or cha-
rybdotoxin (ChTX) (0.1 M), and the large conductance calcium-
activated potassium channel (BKCa or KCa1.1) blocker iberiotoxin
(IbTX) (0.1 M). After 30 min of incubation with inhibitor and/or
blocker, segments were contracted with U46619 (10–40 nM) to con-
strict the vessel to 60% of its resting diameter. When contraction was
stable, cumulative concentration-response curves for NS309
(0.001–1 M) were constructed, and changes in diameter were re-
corded.
Simultaneous Measurements of Force and NO. Superior and
third-order small mesenteric arteries (internal diameter, 238  26
m; n  20) were mounted on two 40-m wires in a wire myograph
(model 310A; DMT) for isometric tension recordings with the nor-
malization procedure and inclusion criteria as described above. For
simultaneous measurement of NO concentration and force, a NO-
sensitive microsensor, either ISONOP3020 (diameter of 30 m) or
ISONOP007 (diameter of 7 m) (World Precision Instruments, Inc.,
Sarasota, FL), first was calibrated by the use of NO gas in solution,
and selectivity was confirmed by the absence of a response to sodium
nitrite (10 M) and noradrenaline (1 M). Changes in NO concen-
tration were recorded using a NO meter (ISO-NO Mark II; World
Precision Instruments, Inc.). The sensor then was introduced into
the lumen of the artery mounted in the myograph. Unless otherwise
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stated, arterial segments always were incubated with indomethacin
(3 M).
To investigate the role of opening SKCa and IKCa channels in NO
production and relaxation, segments were incubated with ADMA
(300 M), the NO scavenger oxyhemoglobin (OxHb) (10 M), apamin
(0.5 M), and TRAM-34 (1 M). After 30 min of incubation with the
inhibitors and/or blockers, segments were contracted with noradren-
alin (0.5 M). When contraction was stable, NS309 (1 M) was added
to the organ bath, and NO concentration was recorded simultane-
ously with force.
Membrane Potential Measurements. Segments from small
mesenteric arteries were mounted on 40-m wires in a myograph
(model 410A; DMT) with the normalization procedure and inclusion
criteria as described above. Microelectrodes (glass, AS100F; World
Precision Instruments, Inc.) were prepared on a horizontal puller
(P-97; Sutter Instrument Company, Novato, CA), filled with 3 M
KCl, and connected to an amplifier (Intra 767; World Precision
Instruments, Inc.). Electrodes with stable resistances (	30 M
)
were used to measure membrane potentials as described previously
(Mulvany et al., 1982). Recordings from smooth muscle cells in small
mesenteric arterial segments were made by advancing the electrode
through the adventitia into the media. Unless otherwise stated, the
segments always were incubated with indomethacin (3 M). The
effect of NS309 (1 M) on membrane potential was investigated in
the presence of ADMA (300 M) alone and in combination with
ChTX (0.1 M) and apamin (0.5 M).
Studies in Isolated Endothelial Cells . HUVECs were isolated
and cultured as described previously (Ostergaard et al., 2007). In
brief, pregnant women attending routine antenatal care at the De-
partment of Obstetrics and Gynecology, Aarhus University Hospital,
Skejby, Denmark, were invited to participate in the study. Written
consent was obtained from those who agreed to participate (n  20).
The investigation conformed to the principles outlined in the Decla-
ration of Helsinki and was approved by the local ethics committee of
Aarhus University (Reference Number 20040154). The umbilical
cords were obtained immediately after delivery. HUVECs were iso-
lated by rinsing the veins with Dulbecco’s modified Eagle’s medium
(DMEM) (Sigma-Aldrich, St. Louis, MO) to remove as much blood as
possible. Then, 10 ml of 0.1% collagenase solution was flushed
through the vein, and the umbilical cord was closed at both ends.
After the incubation for 1 h at 37°C, the umbilical cord was washed
with 20 ml of DMEM with 10% fetal calf serum. The cells were spun,
and the pellet was resuspended in growth medium containing 2%
serum, epidermal growth factor, hydrocortisone, vascular endothe-
lial growth factor, fibroblast growth factor, insulin growth factor,
ascorbic acid, heparin, amphotericin B, and gentamicin (Endothelial
Cell Growth Medium 2 with SupplementPack; PromoCell, Heidel-
berg, Germany). Cells were then plated on gelatin-coated flasks or
dishes and allowed to adhere overnight. Growth medium was
changed every second day, and the cells were passaged with 0.25%
trypsin when confluent. In all of the experiments, cells were used at
passage one or two. The endothelial phenotype was confirmed using
phase-contrast microscopy (i.e., cuboidal, cobblestone-appearing
monolayer of cells) and positive immunofluorescence staining for
anti-von Willebrand factor (1:4000; Dako Denmark A/S, Glostrup,
Denmark).
Isolation of endothelial cells from the superior mesenteric artery
was carried out using protocols described previously (Bra¨hler et al.,
2009). In brief, a 1- to 2-cm segment of the superior mesenteric artery
was dissected from the mesenteric bed and cleaned of fat and con-
nective tissue. The segment was mounted on a small glass capillary
and filled with a trypsin (0.25%)/EDTA buffer (Biochrom, Berlin,
Germany). After being filled, the superior mesenteric artery was
sutured and incubated for 45 min at 37°C. Thereafter, the vessel was
cut open, and the luminal surface was scraped gently with a 10-l
pipette tip. Detached single endothelial cells and endothelial cell
clusters were aspirated and transferred to a culture dish containing
DMEM supplemented with 10% fetal calf serum and penicillin/strep-
tomycin (Biochrom) and cover slips. Cells were allowed to settle
down for 2-4 h and used for calcium measurements within 24 h.
Quantitative Polymerase Chain Reaction. RNA extraction
from HUVECs was performed using TRIzol reagent (Invitrogen,
Carlsbad, CA) according to the manufacturer’s instructions. Total
RNA then was treated with DNase I (QIAGEN Nordic, Copenhagen,
Denmark). The concentration of the RNA was estimated by optical
density measurements at 260 nm. Total RNA (100 g/ml) then was
reverse-transcribed using oligo(dT) primer and Superscript III re-
verse transcriptase (Invitrogen).
Expression of SKCa, IKCa, and BKCa channels was assessed by
TaqMan quantitative polymerase chain reaction (QPCR). Two-hun-
dred nanograms of RNA was used in a 25-l reaction, and QPCR was
conducted using Ex Taq polymerase (Takara Bio Inc., Shiga, Japan).
The following cycles were run: 1 cycle at 95°C for 2 min, 40 cycles at
95°C for 15 s, 1 cycle at 55°C for 1 min, and 1 cycle at 70°C for 15 s
on a Stratagene Mx3000P machine (Agilent Technologies, Santa
Clara, CA). Primer and fluorogenic probes were designed using
PerlPrimer (Eurofins MWG Operon, Huntsville, AL). The probe con-
tained the reporter dye 6-carboxyfluorescein at the 5 end and the
Black Hole Quencher 1 dye at the 3 end. The following primers and
probes were used: glyceraldehyde-3-phosphate dehydrogenase
(GAPDH) (GenBank accession no. BC_023632), forward (237–259),
5-AAA TCC CAT CTT CCA GG-3, reverse, (338–355), 5-AGC CCC
AGC CTT CTC CA-3, probe (290–317), 5-ATG CTG GCG CTG AGT
ACG TCG TGG AGT-3; BKCa (GenBank accession no. U13913),
forward (3010–3030), 5-TTC CTC AGC AAT CAG AGC CTC-3,
reverse (3121–3141), 5-ACA GCA TTT GCC GTC AGT GTC-3,
probe (3067–3099), 5-AAT ATC CTC ACC CTG ATA CGG ACC CTG
GTG ACC-3; IKCa (GenBank accession no. NM_002250), forward
(1368–1390), 5-GTT CTA CAA ACA TAC TCG CAG GA-3, reverse
(1572–1592), 5-GCG TGT CAA TCT GTT TCT CAA-3, probe (1439–
1467), 5-TCA ACG CGT TCC GCC AGG TGC GGC TGA AA-3;
SKCa2.3 (GenBank accession no. NM_002249), forward (2087–2107),
5-GAT TGA CCA TGC CAA AGT GAG-3, reverse (2210–2230),
5-ACA TGA CAT TCT GCA TCT TGG-3, probe (2125–2149), 5-
TCC TCC AAG CTA TCC ACC AGT TGA G-3.
Patch Clamp. HUVECs were dispersed using 0.25% trypsin or
nonenzymatic cell dissociation solution (Sigma-Aldrich) and seeded
onto glass coverslips 1 h before the start of the experiments. Once
cells had attached, patch-clamp experiments were performed at room
temperature (20°C). Patch pipettes were fabricated from borosili-
cate glass and had a resistance of 3 to 6 M
 after being fire polished.
Membrane currents were measured using the conventional whole-
cell patch-clamp configuration with an EPC 10 patch-clamp ampli-
fier controlled by Pulse Trace 8.65 (HEKA, Lambrecht, Germany)
connected to a computer. Currents were recorded using an extracel-
lular solution containing: 105 mM NaCl, 25 mM NaHCO3, 4.7 mM
KCl, 1.18 mM KH2PO4, 1.17 mM MgSO4, 10 mM HEPES, 0.026 mM
EGTA, 5.5 mM glucose, and 1.6 mM CaCl2 (pH 7.4). In some exper-
iments, CaCl2 was omitted from the solution (Ca-free extracellular
solution). The pipette solution contained: 30 mM KCl, 100 mM po-
tassium aspartate, 1 mM MgCl2, 10 mM EGTA, 3 mM Na2ATP, 5
mM HEPES, and 8.5 mM CaCl2 (pH 7.2). Free [Ca
2] in the pipette
solution was estimated to be 1 M, and free [Mg2] was 50 M
(calculated by Winmaxc32, version 2.50, http://www.stanford.edu/
cpatton/maxc.html, using the constants in CMC0204E.TCM). In
some experiments, CaCl2 was omitted from the solution (Ca-free
pipette solution). Currents were sampled at 2 kHz and analyzed
using PatchMaster software (HEKA). Series resistances were 5
M
 and were not compensated for. Current-voltage (I/V) relation-
ships were constructed using a holding membrane potential of 60
mV and by stepping from 120 to 120 mV in 40-mV increments for
200 ms. Currents measured at a step holding potential of 80 mV were
used to compare the effects of NS309 (0.1 and 1 M) in the absence
and presence of apamin (0.3 M), ChTX (0.1 M), TRAM-34 (1 M),
IbTX (0.1 M), and glibenclamide (0.1 M).
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Measurements of NO Concentration in HUVECs. HUVECs
were seeded onto glass coverslips coated with gelatin (0.5%). After
cells reached a confluence of 50-70%, the coverslips were transferred
into an organ bath, a NO-sensitive microsensor with a diameter of 30
m (ISONOP30; World Precision Instruments, Inc.) was placed
above the HUVECs, and changes in NO concentration were recorded
as described above.
Measurements of Intracellular Ca2. For measurements of
intracellular Ca2 concentration [Ca2]i, HUVECs were seeded onto
gelatin-coated glass coverslips (0.5%) and loaded with FURA-2-AM
(4 M) for 30 min. After being loaded, cells were transferred into a
perfusion chamber (Warner Instruments, Hamden, CT). Ratio im-
ages of 340/380 nm were used for the measurement of increases in
[Ca2]i as described previously (Ostergaard et al., 2007). To investi-
gate the effects of opening of SKCa and IKCa channels on [Ca
2]i,
NS309 was applied in three different concentrations (0.01, 0.1, and 1
M) in the absence and the presence of TRAM-34 (1 M) and com-
pared with the effect of histamine (1 M). Maximum [Ca2]i was
estimated by the addition of ionomycin (1 M).
For calcium measurements, the mesenteric endothelial cells were
loaded with a buffer consisting of the visible light excitable calcium
indicator Oregon Green BAPTA-1-AM (7.24 mM), the nonionic sur-
factants Cremophor EL [0.066% (w/v)] and Pluronic F-127 (10.66
mM), and dimethylsulfoxide (DMSO) [0.32% (w/v)] at 37°C for 20
min in PSS. The solutions were equilibrated with bioair of the
following composition: 5% CO2, 21% O2, and 74% N2. Image acqui-
sition of endothelial cell calcium was performed with an inverted
confocal microscope (model LSM 510 Exciter; Carl Zeiss GmbH,
Jena, Germany) equipped with a 63, numerical aperture 0.75 long
working distance objective excited at a wavelength of 488 nm using
the Zeiss LSM Image Browser software program (Carl Zeiss GmbH).
To investigate the effects of opening of SKCa and IKCa channels on
[Ca2]i, NS309 (1 M) was applied in the absence and the presence
of TRAM-34 (1 M) and extracellular Ca2 and compared with the
effect of ACh (10 M). Maximum [Ca2]i was estimated by the
addition of ionomycin (1 M).
Drugs. ACh, ADMA, IbTX, glibenclamide, indomethacin, nor-
adrenalin, TRAM-34, Cremophor EL, Pluronic F-127, DMSO, and
U46619 were purchased from Sigma-Aldrich. Apamin and ChTX
were purchased from Latoxan (Valence, France). FURA-2-AM and
Oregon Green BAPTA-1-AM were obtained from Invitrogen. NS309
was kindly donated by Dr. Joachim Demnitz (NeuroSearch A/S,
Ballerup, Denmark). Indomethacin was prepared in PSS without
CaCl2 (PSS0.0). NS309 and glibenclamide stock solutions were dis-
solved in DMSO and further diluted in distilled water. The total
amount of DMSO never exceeded 1% in organ baths and did not
affect any of the results. All of the other drugs were prepared in
distilled water.
Data and Statistical Analysis. For the isometric tension record-
ings, the stable tension after each addition of NS309 was expressed
as a percentage of the active tension, where the active tone was
defined as the level of contraction after the addition of noradrenalin
minus the level of contraction after the normalization procedure. For
NO measurements, NO concentrations and relaxation were mea-
sured 3 min after exposure to S-nitroso-N-acetylpenicillamine
(SNAP), ACh, or NS309. For calcium measurements, the relative
increases in fluorescence intensity (F/F0) of FURA-2-AM or Oregon
Green BAPTA-1-AM were used for the measurement of the increases
in [Ca2]i. For QPCR measurements, the amount of cDNA was
normalized to the reference gene by using the threshold Ct values,
Ct  Ct(target)  Ct(GAPDH), and the results were analyzed as a
ratio to the GAPDH expression, ratio  2Ct. For patch-clamp
studies, the changes in current were expressed relative to the capac-
itance of the cell. Results are expressed as mean  S.E.M. and
analyzed by a Student’s t test or a two-way analysis of variance
(ANOVA) as appropriate. P  0.05 was considered significant.
Results
Effects of an Opener of SKCa and IKCa Channels,
NS309, in Rat Superior Mesenteric Arteries. To investi-
gate the effect of opening SKCa and IKCa channels on relax-
ation and the relative contributions from NO and EDHF-type
relaxation in a larger sized artery, NS309-induced NO re-
lease and relaxation in superior mesenteric arterial seg-
ments were investigated. NS309 (0.01–10 M) induced con-
centration-dependent relaxations (EC50, 1.4 1.2 M; n 7)
that were endothelium dependent. Inhibition of NO synthase
with ADMA (300 M) and blocking IKCa channels with
TRAM-34 (1 M) reduced NS309-induced relaxation (EC50,
5.6  1.4 and 15.3  3.1 M, respectively; n  7), whereas
blocking SKCa channels with apamin (0.3 M) had no effect
on NS309-induced relaxation (EC50, 1.7  1.4 M; n  5).
NS309-induced relaxation was not decreased further when
both SKCa and IKCa channels were blocked simultaneously
(EC50, 17.4 4.8 M; n 7) compared with blocking only the
IKCa channels. Inhibition of NO synthase and blocking both
IKCa and SKCa channels reduced NS309-induced relaxation
to the same level as removal of the endothelium (Fig. 1A).
Blocking BKCa channels reduced NS309 relaxation in rat
superior mesenteric artery (Fig. 2A) and shifted concentra-
tion-response curves rightward for the NO donor SNAP (U.
Simonsen, unpublished observations).
Simultaneous measurements of NO release and relaxation
in superior mesenteric arteries showed that ACh (10 M)
increased NO release to 22.9  2.1 nM (n  5), which was
accompanied by relaxation of 87.9  5.2% (n  5). Inhibition
of NO synthase by ADMA (300 M) reduced ACh-induced
increases in NO and relaxation to 3.1  0.5 nM and 65  7%
(n  5), respectively. Likewise, NS309 (1 M) increased NO
release to 20.1  1.7 nM, resulting in 22.9  4% relaxation
(n  6). ADMA reduced NS309-induced NO release to 4.1 
1.6 nM and abolished NS309-induced relaxation (n  6). In
the presence of apamin (0.5 M) and TRAM-34 (1 M),
NS309-induced release of NO and relaxation were reduced to
4.4  1.3 nM and 4.3  2.5%, respectively (n  5). Finally, in
the presence of the NO scavenger OxHb (10 M), NS309
failed to release NO and cause relaxation (Fig. 1, B and
C; n  6).
Effects of an Opener of SKCa and IKCa Channels,
NS309, in Small Mesenteric Arteries. To investigate the
effect of opening SKCa and IKCa channels on relaxation and
the relative contributions from NO and EDHF-type relax-
ation in a smaller sized artery, NS309-induced release of NO
and relaxation in small mesenteric arterial segments were
investigated. NS309 (0.001–1 M) induced potent concentra-
tion-dependent relaxations (EC50, 39  12 nM; n  7). Inhi-
bition of NO synthase with ADMA (300 M) reduced NS309-
induced relaxations only at the highest concentration (1 M)
(EC50, 72  16 nM; n  7), whereas blocking SKCa channels
with apamin (0.5 M) (EC50, 0.62  0.13 M; n  7) or
blocking IKCa channels with TRAM-34 or ChTX (0.1 M)
(EC50, not available; n  4 and n  7, respectively) led to a
much higher reduction of NS309 relaxation. Inhibition of NO
synthase and blocking both SKCa and IKCa channels abol-
ished NS309-induced relaxations (n  7) (Fig. 3A). Blocking
BKCa channels with IbTX (0.1 M) had no effect on NS309-
induced relaxations in mesenteric small arteries (Fig. 2B).
In small mesenteric arteries, ACh (10 M) hyperpolarized
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the smooth muscle cell membrane (Vm, 25.3  2.5 mV;
n  5). ACh-induced hyperpolarizations were reduced in the
presence of ADMA (300 M) (Vm, 17.3  2.0 mV; n  5)
and abolished by simultaneous inhibition of NO synthase
with ADMA (300 M), blocking SKCa channels with apamin
(0.5 M), and blocking IKCa channels with ChTX (0.1 M)
(Vm, 0.6  1.5 mV; n  4). NS309 (1 M) also hyperpolar-
ized smooth muscle cell membrane (Vm, 17.7  2.3 mV;
n  6). Treatment with ADMA alone had no effect on the
membrane potential (Vm, 11.7  2.3 mV; n  4), whereas
the combination of ADMA, apamin, and ChTX abolished
NS309-induced hyperpolarization (Vm, 0.4  1.9 mV; n 
4) (Fig. 3B).
Simultaneous measurement of NO release and relaxation
in small mesenteric arteries showed that ACh (10 M) in-
creased NO concentration to 8.8  2.0 nM and relaxed the
arteries by 100  1% (n  4). Inhibition of NO synthase by
ADMA (300 M) markedly reduced NO release (Fig. 3C) but
only reduced the peak relaxation induced by ACh to 91  5%
(P  0.05; n  3). Addition of NS309 (1 M) increased the
luminal NO concentration to 10.1  2.0 nM and relaxed the
arteries by 57  10% (Fig. 3C).
Effects of an Opener of SKCa and IKCa Channels,
NS309, in Isolated Endothelial Cells. In HUVECs, SKCa3
mRNA showed 30 times higher expression than IKCa
mRNA, whereas no expression of BKCa mRNA was found
(Fig. 3A). NS309 (0.1 and 1 M) increased the outward cur-
rent in HUVECs. The NS309-induced increase in outward
current was abolished in the absence of intra- and extracel-
lular Ca2 (Fig. 3B). When the involvement of different po-
tassium channels in the NS309-induced increase in current
was investigated, ChTX (0.1 M) or TRAM-34 (1 M) abol-
ished the increase in current, and apamin (0.3 M) reduced
the increase in outward current, whereas IbTX (0.1 M) or
glibenclamide (0.1 M) had no effect on the increase in cur-
rent (Fig. 4, C and D).
In HUVECs, histamine (1 M) increased the release of NO
to 8.95  0.2 nM (n  6). In the presence of apamin (0.5 M)
and TRAM-34 (1 M), the response to histamine was reduced
to 6.36  0.1 nM (n  7) (Fig. 5, A and B). When TRAM-34
was replaced with ChTX (0.1 M), the histamine-induced
release of NO was reduced to 1.9  2.1 nM (n  6). In the
Fig. 1. Effect of blocking NO synthase and SKCa and IKCa channels on
NS309-induced release of NO and relaxation in rat superior mesenteric
arteries. A, isometric tension recordings showing the relaxing effect of
NS309 in the absence and presence of ADMA (300 M), apamin (0.5 M),
and TRAM-34 (1 M). All of the experiments were performed in the
presence of indomethacin (3 M). Results are mean  S.E.M. n  5–7.
Two-way ANOVA. , P  0.05 from control. B, original trace showing
NS309-induced NO release and relaxation in a rat superior mesenteric
artery contracted with noradrenaline (0.5 M). C, average increase in NO
concentration evoked by NS309 in the absence and presence of apamin
(0.5 M), TRAM-34 (1 M), ADMA (300 M), and OxHb (10 M). All of
the experiments were performed in the presence of indomethacin (3 M).
Results are mean  S.E.M. n  5–6. Student’s t test. , P  0.05 from
control.
Fig. 2. Effect of blocking BKCa channels on NS309 relaxation in large and
small rat mesenteric arteries. Isometric tension recordings in rat superior
mesenteric artery (A) and isobaric diameter recordings in small mesen-
teric arteries (B) showing the relaxing effect of NS309 in the absence and
presence of a blocker of BKCa channels (0.1 M). All of the experiments
were performed in the presence of indomethacin (3 M). Results are
mean  S.E.M. n  5–6. Two-way ANOVA. , P  0.05 from control.
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presence of ADMA (300 M), apamin, and ChTX, the hista-
mine-induced release of NO was reduced to 0.7 0.4 nM (n
6). NS309 (1 M) increased the NO concentration to 12.9 
1.8 nM (n  5), which was reduced to 6.4  2.0 nM (n  5) in
the presence of apamin (0.5 M) and TRAM-34 (1 M) (Fig.
5, A and B).
In HUVECs loaded with FURA-2-AM, histamine (1 M)
increased whole-cell [Ca2]i by 0.36  0.03 (n  6), whereas
stimulation with NS309 (0.01 M) increased [Ca2]i by
0.06  0.02 (n  6). Increasing the concentration of NS309 to
0.1 and 1 M had no further effect on whole-cell [Ca2]i (Fig.
5C). TRAM-34 (1 M) decreased basal [Ca2]i by 0.27  0.03
(n  6), reduced the histamine-induced increase in [Ca2]i to
0.26  0.03 (n  6), and abolished the NS309-induced in-
crease in [Ca2]i (Fig. 5C).
In mesenteric arterial endothelial cells loaded with Oregon
Green BAPTA-1-AM, both ACh (10 M) and NS309 (1 M)
increased whole-cell [Ca2]i in the presence of extracellular
Ca2 (0.27  0.04 and 0.10  0.01, respectively; n  5–6). In
contrast, in the absence of extracellular Ca2, NS309 (1 M)
failed to change [Ca2]i (0.02 0.02; n 3), whereas ACh (10
M) induced a transient increase (0.07  0.03; n  3) (Fig.
5D). In the presence of TRAM-34 (1 M), ACh and NS309
induced less increase in [Ca2]i (0.16  0.01 and 0.04  0.01,
respectively; n  4), and ionomycin-induced increases in
calcium were unaltered (0.66  0.08 and 0.68  0.16, respec-
tively; n  5) (Fig. 5D).
Discussion
The main findings of the present study are that NS309
induces endothelium-dependent relaxations that are medi-
ated largely by the release of NO in superior mesenteric
arteries, whereas NS309 induces hyperpolarization and
EDHF-type relaxation in small mesenteric arteries. In
HUVECs, NS309 increased current sensitive to SKCa and
IKCa channel blockers, but the current remained unaltered in
the presence of a blocker of BKCa channels, IbTX. Moreover,
NS309-induced calcium influx appears to contribute to the
formation of NO.
Contributions of NO and EDHF to NS309-Induced
Relaxation. NS309 induced more potent relaxations in
small arterial segments compared with those in superior
mesenteric arterial segments in the present study. Compared
with isometric preparations, the membrane potential of pres-
surized arteries is more depolarized (Schubert et al., 1996),
and together with the observations that smooth muscle hy-
perpolarization induced by an endothelium-dependent vaso-
dilator (e.g., ACh) is attributable to SKCa channels, whereas
IKCa channels play an important role during the ACh-in-
duced repolarization phase after the depolarization (Crane et
al., 2003), we cannot exclude the possibility that this may
contribute to the different potency of NS309 observed in large
versus small mesenteric arteries in the present study. How-
ever, calcium-activated potassium channels were suggested
to play a role in the regional heterogeneity in ACh-induced
relaxation in the rat mesenteric vascular bed (Hilgers et al.,
2006), and that also may contribute to the different potency
of NS309 in large versus small arteries. In both the superior
and the small mesenteric arteries, NS309 relaxation was
markedly inhibited in the presence of blockers of IKCa chan-
nels and further reduced by the combined inhibition of IKCa
and SKCa channels, suggesting that the endothelium-depen-
dent relaxations induced by NS309 involve IKCa and SKCa
channels. In contrast to the small mesenteric arteries, the
BKCa-selective blocker IbTX also reduced NS309 relaxation,
but it also reduced relaxation in response to the NO donor
SNAP, suggesting that the effect of IbTX on NS309 relax-
ation probably can be attributed to smooth muscle BKCa
channels activated by NO in rat superior mesenteric artery.
We have found in previous studies that endothelial SKCa
and IKCa channels contribute to ACh-induced endothelial
hyperpolarization and NO-mediated relaxation in large ar-
teries (Stankevicius et al., 2006). Moreover, in an endothelial
cell line (EA.hy926) derived from human umbilical vein, in-
Fig. 3. Effect of blocking NO synthase and SKCa and IKCa channels on
NS309-induced release of NO and relaxation in small rat mesenteric
arteries. A, isobaric diameter recordings showing the relaxing effect of
NS309 in the absence and presence of ADMA (300 M), apamin (0.5 M),
ChTX (0.1 M), TRAM-34 (1 M), and apamin plus ChTX. All of the
experiments were performed in the presence of indomethacin (3 M).
Results are mean  S.E.M. n  7. Two-way ANOVA. , P  0.05 from
control. B, smooth muscle cell hyperpolarizations induced by ACh (10
M) and NS309 (1 M) in the absence and presence of apamin (0.5 M),
ChTX (0.1 M), and ADMA (300 M). All of the experiments were
performed in the presence of indomethacin (3 M). Results are mean 
S.E.M. n  4–6. Student’s t test: , P  0.05 from control. C, average
trace (n  3) showing SNAP- (10 M), ACh- (10 M), and NS309-induced
(1 M) NO release and relaxation in the absence and presence of indo-
methacin (3 M) and ADMA (300 M) in small mesenteric arteries
contracted with noradrenaline (0.5 M).
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hibition of SKCa and IKCa channels decreased, whereas open-
ers of SKCa and IKCa channels were found to increase NO-
sensitive DAF-FM fluorescence (Sheng et al., 2009). In the
present study, an opener of SKCa and IKCa channels, NS309,
increased the NO concentration in superior mesenteric arter-
ies and primary cultured HUVECs, providing direct evidence
that opening of SKCa and IKCa channels is involved in the
release of NO in large arteries.
Opening endothelial SKCa and IKCa channels is thought to
be pivotal for EDHF-type relaxation, and inhibition of these
channels by the combination of apamin and ChTX has been
considered as a unique characteristic of non-NO, nonprostan-
oid-type relaxations (Edwards et al., 1998; Buus et al., 2000)
and hyperpolarization evoked by agonists in small arteries
(Zygmunt and Ho¨gesta¨tt, 1996; Edwards et al., 1998;
Yamamoto et al., 1999). Confirming these previous studies,
this study found that ACh-induced hyperpolarizations and
relaxations also were blocked when apamin and ChTX were
added together with an inhibitor of NO synthase in rat mes-
enteric small arteries (Fig. 3). This also was the case for
NS309-induced hyperpolarizations and relaxations in rat
mesenteric small arteries, suggesting that, in this prepara-
tion, an EDHF is the main contributor to NS309-induced
hyperpolarizations and relaxations. However, NO has been
Fig. 4. SKCa and IKCa channel currents
and expression in HUVECs. A, QPCR
showing the expression of SKCa2.3,
IKCa, and BKCa RNA. B and C, current-
voltage relationships derived from
whole-cell patch-clamp experiments
showing the effect of NS309 on whole-
cell currents in the presence and ab-
sence of intracellular Ca2, apamin (0.3
M), and ChTX (0.1 M). Results are
mean  S.E.M. n  4–7. Two-way
ANOVA. , P  0.05 from control with
calcium. #, P  0.05 from NS309 (0.1
M,Ca2). $, P 0.05 from NS309 (1
M). D, relative NS309-induced in-
crease in current at 80 mV after the
addition of various potassium channel
blockers: apamin (0.3 M), ChTX (0.1
M), TRAM-34 (1 M), IbTX (0.1 M),
and glibenclamide (0.1M). Results are
mean  S.E.M. n  4–7. Student’s t
test. , P  0.05 from NS309.
Fig. 5. NS309-induced release of NO
and increase in intracellular Ca2 in
isolated endothelial cells. A, original
recording showing NS309-induced (1
M) NO release in HUVECs. B, aver-
age increase in NO concentration in-
duced by NS309 (1 M) in the absence
and presence of apamin (0.5 M) and
TRAM-34 (1 M). Results are mean 
S.E.M. n  5–7. Student’s t test. ,
P  0.05 from control. C, histamine-
(1 M) and NS309-induced (1 M) in-
crease in intracellular Ca2 concen-
tration in HUVECs in the absence
and presence of TRAM-34 (1 M). Re-
sults are mean  S.E.M. n  6. Stu-
dent’s t test. , P  0.05 from hista-
mine control. Two-way ANOVA. ,
P  0.05 from NS309 controls. D, rel-
ative increase in rat mesenteric endo-
thelial cell calcium after the addition
of ACh (10 M), NS309 (1 M), and
ionomycin (1 M) in the absence and
presence of TRAM-34, an IKCa chan-
nel blocker, and of ACh (10 M) and
NS309 (1 M) in the absence of extra-
cellular calcium. Results are mean 
S.E.M. (n  3–5). Student’s t test. ,
P  0.05 from control.
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suggested previously to contribute to EDHF-type relaxation
and hyperpolarization induced by ACh in rat mesenteric
arteries (Chauhan et al., 2003). In the present study, ADMA
also inhibited ACh-induced hyperpolarizations and abolished
increases in NO concentration in rat small mesenteric arter-
ies, hence providing further support that NO contributes to
EDHF-type vasodilation in this preparation. Therefore, in
addition to contributing to the main EDHF component, NO
also contributes to the sustained ACh-induced relaxation in
rat small mesenteric arteries.
In porcine retinal arteries, we found that NS309 as well as a
selective opener of SKCa channels, CyPPA, induced apamin-
sensitive, NO-mediated relaxations and potentiation of brady-
kinin relaxations, suggesting that SKCa channels are coupled to
the release of NO from the endothelial cell layer (Dalsgaard et
al., 2009, 2010a). Moreover, down-regulation of the SKCa3 chan-
nel in mice appears to inhibit N-nitro-L-arginine methyl ester-
sensitive bradykinin relaxation in carotid arteries (Bra¨hler et
al., 2009). However, in the present study, TRAM-34 both re-
duced release of NO and abolished endothelium-dependent re-
laxation induced by NS309 in rat superior mesenteric artery,
suggesting that mainly IKCa channels are coupled to the release
of NO in this preparation. Thus, depending on the vascular bed
and/or the specific endothelial cell compartmentalization, either
SKCa or IKCa channels may be coupled to the release of NO.
Cellular Mechanisms Involved in Responses to NS309.
In the present study, we found that in primary HUVECs both
SKCa3 and IKCa channels were expressed, whereas BKCa chan-
nel expression was undetectable. These findings agree with
previous work in early passage HUVECs (Kestler et al., 1998)
and our previous observations that an opener of BKCa channels,
1-(3,5-bis-trifluoromethyl-phenyl)-3-[4-bromo-2-(1H-tetrazol-5-
yl)-phenyl]-thiourea) (NS11021), does not change the current-
voltage relationship in early passage HUVECs (Kun et al.,
2009). Furthermore, our patch-clamp studies in HUVECs indi-
cated that the increased potassium conductance induced by
NS309 was dependent on the presence of [Ca2]i and that it was
inhibited partially by apamin and abolished by ChTX and
TRAM-34, whereas it remained unaltered in the presence of
IbTX. In conjunction with the more marked inhibition of vaso-
dilation in response to NS309 by blockers of IKCa channels (Fig.
1), these data suggest that IKCa channels may play a more
prominent role in the response to NS309 in HUVECs and iso-
lated arteries.
Opening of potassium channels will draw the membrane
potential toward the equilibrium potential for potassium and
lead to hyperpolarization. In endothelial cells, hyperpolariza-
tion is thought to increase the driving force for the influx of
Ca2 via cation channels belonging to transient receptor
potential ion channels (e.g., transient receptor potential cat-
ion channels and transient receptor potential cation channel
subfamily V member 4) and thereby prolongs and strength-
ens the activating Ca2 signal (Nilius and Droogmans, 2001;
Earley and Brayden, 2010). Inhibition of calcium-activated
potassium channels is associated with a decrease in [Ca2]i
(Nilius and Droogmans, 2001; Sheng and Braun, 2007).
Moreover, studies in an endothelial cell line (EA.hy926) de-
rived from human umbilical veins suggested that opening
SKCa channels was associated with an increase in Ca
2 and
NO formation (Sheng and Braun, 2007; Sheng et al., 2009).
In the present study, both histamine and NS309 increased
[Ca2]i and NO release in HUVECs, and in both cases, the
increase in NO was reduced by incubation with TRAM-34
and apamin. These results suggest that opening of SKCa and
IKCa channels is involved in the effects of histamine and
NS309 and is therefore consistent with the view that mem-
brane hyperpolarization by opening of SKCa and IKCa chan-
nels leads to increased influx of extracellular Ca2. More-
over, the findings that in freshly isolated mesenteric arterial
cells the increase in [Ca2]i induced by NS309 was reduced
markedly by TRAM-34 and completely abolished in the ab-
sence of extracellular calcium suggest that opening of IKCa
channels is coupled to calcium influx.
In contrast to isolated endothelial cell studies, openers of
SKCa and IKCa channels (e.g., NS309) fail to change Ca
2 in
intact segments of retinal (Dalsgaard et al., 2010a) and rat
small mesenteric arteries (Brøndum et al., 2010), and a com-
bination of apamin plus ChTX fails to change agonist-in-
duced increases in endothelial cell Ca2 in rat superior mes-
enteric artery and small mesenteric arteries (Ghisdal and
Morel, 2001; McSherry et al., 2005; Stankevicius et al., 2006).
Despite comparable increases in NO concentration, the in-
crease in [Ca2]i was much more marked with histamine
compared with that with NS309 in HUVECs and with ACh
compared with that with NS309 in mesenteric arterial endo-
thelial cells in the present study. These findings suggest that,
also in isolated endothelial cells, it is questionable whether
the increase in [Ca2]i can account completely for the in-
crease in NO seen with NS309. Thus, these findings suggest
that Ca2-independent events also may couple SKCa and
IKCa channel opening to changes in the release of NO as
proposed either through membrane potential regulation of
superoxide production and/or L-arginine uptake (Dalsgaard
et al., 2010b). Moreover, it was suggested recently that po-
tassium efflux resulting in an acute increase of potassium in
the physiological range swells endothelial cells and hence
may increase the release of NO (Oberleithner et al., 2009).
However, further studies are required to clarify how activa-
tion of these mechanisms is coupled to increased formation of
NO in endothelial cells.
Conclusion and Perspectives
In conclusion, in superior mesenteric arteries, NS309-in-
duced relaxation was mediated mainly by NO, whereas in
small mesenteric arteries, NS309-induced relaxation was
mediated mainly by EDHF. NS309-induced calcium influx
appears to contribute to the formation of NO. These results
suggest that treatment with SKCa and IKCa channel openers
in atherosclerotic or hypertensive disease involving a reduc-
tion in blood flow will not only improve blood flow in vascular
beds, where the relative contribution from EDHF-type vaso-
dilation is high, such as in coronary vasodilation from en-
hanced perfusion pulsatility (Paolocci et al., 2001), but also
may improve blood flow in vascular beds, where the relative
contribution from NO to vasodilation is high.
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